Regulation of CLU Gene Expression by Oncogenes and Epigenetic Factors: Implications for Tumorigenesis

被引:44
作者
Sala, Arturo [1 ]
Bettuzzi, Saverio [5 ,6 ]
Pucci, Sabina [2 ]
Chayka, Olesya [1 ]
Dews, Michael [3 ,4 ]
Thomas-Tikhonenko, Andrei [3 ,4 ]
机构
[1] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London WC1E 6BT, England
[2] Univ Roma Tor Vergata, Inst Pathol Anat, Dept Biopathol, Rome, Italy
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[5] INBB, Rome, Italy
[6] Univ Parma, Dipartimento Med Sperimentale, Sez Biochim Biochim Clin & Biochim Esercizio Fis, I-43100 Parma, Italy
来源
ADVANCES IN CANCER RESEARCH, VOL 105 | 2009年 / 105卷
关键词
NF-KAPPA-B; APOLIPOPROTEIN-J CLUSTERIN; PROSTATE EPITHELIAL-CELLS; GROWTH-FACTOR-BETA; C-MYC; IN-VITRO; INDUCED APOPTOSIS; CANCER CELLS; SULFATED GLYCOPROTEIN-2; CYCLE PROGRESSION;
D O I
10.1016/S0065-230X(09)05007-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In no other field has the function of clusterin (CLU) been more controversial than in cancer genetics. After more than 20 years of research, there is still uncertainty with regard to the role of CLU in human cancers. Some investigators believe CLU to be all oncogene, others-an inhibitor of tumorigenesis. However, owing to the recent efforts of several laboratories, the role of CLU in important cellular processes like proliferation, apoptosis, differentiation, and transformation is beginning to emerge. The "enigmatic" CLU is becoming less so. In this chapter, we will review the work of research teams interested in understanding how CLU is regulated by oncogenic signaling. We will discuss how and under what circumstances oncogenes and epigenetic factors modify CLU expression, with important consequences for mammalian tumorigenesis. (C) 2009 Elsevier Inc.
引用
收藏
页码:115 / 132
页数:18
相关论文
共 85 条
  • [1] Arango D, 2001, CANCER RES, V61, P4910
  • [2] Bettuzzi S, 2000, CANCER RES, V60, P1472
  • [3] Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression
    Bettuzzi, S
    Scorcioni, F
    Astancolle, S
    Davalli, P
    Scaltriti, M
    Corti, A
    [J]. ONCOGENE, 2002, 21 (27) : 4328 - 4334
  • [4] Mornings with art, lessons learned: Feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses
    Bey, Erik A.
    Wuerzberger-Davis, Shelly M.
    Pink, John J.
    Yang, Chin-Rang
    Araki, Shinako
    Reinicke, Kathryn E.
    Bentle, Melissa S.
    Doing, Ying
    Cataldo, Eva
    Criswell, Tracy L.
    Wagner, Mark W.
    Li, Longshan
    Gao, Jinming
    Boothman, David A.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 209 (03) : 604 - 610
  • [5] TGFβ:: the molecular Jekyll and Hyde of cancer
    Bierie, Brian
    Moses, Harold L.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (07) : 506 - 520
  • [6] The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression
    Caporali, A
    Davalli, P
    Astancolle, S
    D'Arca, D
    Brausi, M
    Bettuzzi, S
    Corti, A
    [J]. CARCINOGENESIS, 2004, 25 (11) : 2217 - 2224
  • [7] Direct transactivation of the anti-apoptotic gene apolipoprotein J (Clusterin) by B-MYB
    Cervellera, M
    Raschella, G
    Santilli, G
    Tanno, B
    Ventura, A
    Mancini, C
    Sevignani, C
    Calabretta, B
    Sala, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) : 21055 - 21060
  • [8] Clusterin, a Haploinsufficient Tumor Suppressor Gene in Neuroblastomas
    Chayka, Olesya
    Corvetta, Daisy
    Dews, Michael
    Caccamo, Alessandro E.
    Piotrowska, Izabela
    Santilli, Giorgia
    Gibson, Sian
    Sebire, Neil J.
    Himoudi, Nourredine
    Hogarty, Michael D.
    Anderson, John
    Bettuzzi, Saverio
    Thomas-Tikhonenko, Andrei
    Sala, Arturo
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (09): : 663 - 677
  • [9] Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer
    Chi, Kim N.
    Zoubeidi, Amina
    Gleave, Martin E.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (12) : 1955 - 1962
  • [10] Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro
    Chung, J
    Kwak, C
    Jin, RJ
    Lee, CH
    Lee, KH
    Lee, SE
    [J]. CANCER LETTERS, 2004, 203 (02) : 155 - 161